In a follow-up to a report last week, Thailand researchers say the World Health Organization (WHO) has expressed in the Ebola therapy developed at Mahidol University in Bangkok. According to Clinical...

Just one day after the announcement that the US Food and Drug Administration (FDA) and Health Canada authorized Tekmira Pharmaceuticals to provide TKM-Ebola for treatment under expanded access protocols...

By

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access...

By

Today, the Obama administration is announcing a comprehensive set of new federal actions to combat the rise of antibiotic-resistant bacteria and protect public health. Additionally, the President’s Council...

By

Scientists at The Scripps Research Institute (TSRI) have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing...

By

Viamet Pharmaceuticals announced Thursday that VT-1129, a potent and selective, oral, antifungal agent, has been granted orphan drug designation by the U.S. Food & Drug Administration (FDA) for the...

By

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever...

By

The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

By

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive...

By

The common macrolide antibiotic, clarithromycin, has been linked to an increase in cardiac deaths, according to researchers at Statens Serum Institut’s Department of Epidemiology Research in Copenhagen. In...